|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 655281-655305 of 2310128 (92406 Page(s) Totally)
<< < 26207 26208 26209 26210 26211 26212 26213 26214 26215 26216 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-02-12T05:48:29Z |
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox?) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum
|
Hsiao S.-M; Chen C.-A; Lin H.-H; Hsieh C.-Y; LING-HUNG WEI |
| 臺大學術典藏 |
2021-03-03T03:01:14Z |
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox?) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum
|
Hsiao S.-M.;Chen C.-A.;Ho-Hsiung Lin;Hsieh C.-Y.;Wei L.-H.; Hsiao S.-M.; Chen C.-A.; HO-HSIUNG LIN; Hsieh C.-Y.; Wei L.-H. |
| 臺大學術典藏 |
2018-09-10T07:47:35Z |
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox®) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum
|
Hsiao, S.-M. and Chen, C.-A. and Lin, H.-H. and Hsieh, C.-Y. and Wei, L.-H.; CHI-AN CHEN; HO-HSIUNG LIN |
| 中國醫藥大學 |
2005 |
Phase II trial of cisplatin, tegafur plus uracil and leucovorin as neoadjuvant chemotherapy in patients with squamous cell carcinoma of the oropharynx and hypopharynx
|
Wang, HM; Hsueh, CT; Wang, CS; Chen, IH; Liao, CT; Tsai, MH; Yeh, SP; Chang, JTC |
| 國立臺灣大學 |
1994 |
Phase II Trial of Intra-Peritoneal Hyperthermo-Chemotherapy in Patients with resected Gastric Cancer
|
Lee, W. J.; Wei, T. C.; Yu, S. C.; 游憲章; Chang, K. J.; 陳楷模; Lee, W. J.; Wei, T. C.; Yu, S. C.; Yu, Sen-Chang; Chang, K. J.; Chen, Kai-Mo |
| 國立臺灣大學 |
1985 |
Phase II Trial of Intraperitoneal Hyperthermo-Chemotherapy in Patients with Resected Gastric Cancer
|
魏達成; Lee, W. J.; Yu, S. C.; 游憲章; Chang, K. J.; 陳楷模; Wei, Ta-Cheng; Lee, W. J.; Yu, S. C.; Yu, Sen-Chang; Chang, K. J.; Cheng, K. M. |
| 國家衛生研究院 |
1998-03 |
Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions
|
Perng, RP; Chen, YM; Wu, MF; Chou, KC; Lin, WC; Liu, JM; Whang-Peng, J |
| 臺大學術典藏 |
2016 |
Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4)
|
Yang L.; Morgan L; Chia-Chi Lin; Brechenmacher T; Collins L; Cosgriff T; Neron Y; Karyakin O; Kowalyszyn R; Kurteva G; Xie L; Motzer R.J; Alyasova A; Ye D; Karpenko A; Li H; Alekseev B |
| 國立臺灣大學 |
2007 |
Phase Ii Trial of the Efficacy and Safety of Sunitinib Malate Monotherapy in Unresectable Hepatocellular Carcinoma
|
鄭安理; CHENG, ANN-LII |
| 臺北醫學大學 |
2010 |
Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer
|
Ocean, Allyson J.;Christos, Paul;Sparano, Joseph A.;Matulich, Dan;Kaubish, Andreas;Siegel, Abby;Sung, Max;Ward, Maureen M.;Hamel, Nancy;Espinoza-Delgado, Igor;Yen, Yun;Lane, Maureen E.; 閻雲 |
| 國立臺灣大學 |
2007 |
Phase Ii Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
林家齊; 徐志宏; 黃昭源; 鄭安理; 蒲永孝; LIN, CHIA-CHI; HSU, CHIH-HUNG; HUANG, CHAO-YUAN; CHENG, ANN-LII; PU, YEONG-SHIAU |
| 臺大學術典藏 |
2020-05-25T07:35:33Z |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Cheng A.-L; Vogelzang N.J; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:17Z |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
Lin C.-C.; Hsu C.-H.; CHAO-YUAN HUANG; Cheng A.-L.; Vogelzang N.J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T00:46:59Z |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Cheng A.-L.;Vogelzang N.J.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Vogelzang N.J.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-09-01T02:02:09Z |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
Lin C.-C.; Hsu C.-H.; Huang C.-Y.; ANN-LII CHENG; Vogelzang N.J.; Pu Y.-S. |
| 臺大學術典藏 |
2022-09-15T01:09:56Z |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma
|
Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Vogelzang N.J.; Pu Y.-S. |
| 國立臺灣大學 |
2007-01 |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High-Dose 5-Fluorouracil and Leucovorin (TP-HDFL) for Metastatic Urothelial Carcinoma
|
Lin, Chia-Chi; Hsu, Chih-Hung; Huang, Chao-Yuan; Cheng, Ann-Lii; Pu, Nicholas J. Vogelzang Yeong-Shiau |
| 臺大學術典藏 |
2021-12-14T23:12:13Z |
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
|
Even, Caroline; Wang, Hung Ming; Li, Shau Hsuan; Ngan, Roger K.C.; Dechaphunkul, Arunee; Zhang, Li; Yen, Chia Jui; Chan, Po Chung; Chakrabandhu, Somvilai; Ma, Brigette B.Y.; Tanasanvimon, Suebpong; Lee, Victor H.F.; PEI-JEN LOU; Li, Zujun; Spira, Alexander I.; Sukari, Ammar; Guigay, Jo€el; McCune, Steven; Gonzalez-Maffe, Juan; Szpakowski, Sebastian; Yao, Yao; Liang, Hongzi; Mataraza, Jennifer; Sechaud, Romain; Manenti, Luigi; Lim, Darren W.T. |
| 國立成功大學 |
2021 |
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
|
Even, C.;Wang, H.-M.;Li, S.-H.;Ngan, R.K.-C.;Dechaphunkul, A.;Zhang, L.;Yen, C.-J.;Chan, P.C.;Chakrabandhu, S.;Ma, B.B.Y.;Tanasanvimon, S.;Lee, V.H.F.;Lou, P.-J.;Li, Z.;Spira, A.I.;Sukari, A.;Guigay, J.;McCune, S.;Gonzalez-Maffe, J.;Szpakowski, Szpakowski S.;Yao, Yao Y.;Liang, H.;Mataraza, J.;Sechaud, R.;Manenti, L.;Lim, D.W.-T. |
| 國立臺灣大學 |
2009 |
Phase Iib/Iii Double-Blind Randomized Trial of Bibw 2992, an Irreversible, Dual Inhibitor of Egfr and Her2 Plus Best Supportive Care (Bsc) Versus Placebo Plus Bsc in Patients with Nsclc Failing 1-2 Lines of Chemotherapy (Ct) and Erlotinib or Gefitinib (Lu
|
楊志新; YANG, CHIH-HSIN |
| 國家衛生研究院 |
2016-05 |
Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)
|
Abou-Alfa, GK;Qin, SK;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, GM;Harris, WP;Chen, ZD;Hubner, R;Meyer, T;Bomalaski, JS;Lin, CC;Chao, Y;Chen, LT |
| 國立成功大學 |
2018 |
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
|
Abou-Alfa, G.K.;Qin, S.;Ryoo, B.-Y.;Lu, S.-N.;Yen, C.-J.;Feng, Y.-H.;Lim, H.Y.;Izzo, F.;Colombo, M.;Sarker, D.;Bolondi, L.;Vaccaro, G.;Harris, W.P.;Chen, Z.;Hubner, R.A.;Meyer, T.;Sun, W.;Harding, J.J.;Hollywood, E.M.;Ma, J.;Wan, P.J.;Ly, M.;Bomalaski, J.;Johnston, A.;Lin, C.-C.;Chao, Y.;Chen, L.-T. |
| 中國醫藥大學 |
2014-01 |
Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis.
|
(K. Kubota);(Y. Ichinose);(G. Scagliotti);(D. Spigel);(J. H. Kim);(T. Shinkai);(K. Takeda);(S.-W. Kim);夏德椿(Te-Chun Hsia);(R. K. Li);(B. J. Tiangco);(S. Yau);(W.-T. Lim);(B. Yao);(Y.-J. Hei);(K. Park)* |
| 國立成功大學 |
2013-09-20 |
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
|
Sequist, Lecia V.; Yang, James Chih-Hsin; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Hirsh, Vera; Mok, Tony; Geater, Sarayut Lucien; Orlov, Sergey; Tsai, Chun-Ming; Boyer, Michael; Su, Wu-Chou; Bennouna, Jaafar; Kato, Terufumi; Gorbunova, Vera; Lee, Ki Hyeong; Shah, Riyaz; Massey, Dan; Zazulina, Victoria; Shahidi, Mehdi; Schuler, Martin |
| 國立臺灣大學 |
2013 |
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
|
Sequist, Lecia V.; Yang, James Chih-Hsin; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Hirsh, Vera; Mok, Tony; Geater, Sarayut Lucien; Orlov, Sergey; Tsai, Chun-Ming; Boyer, Michael; Su, Wu-Chou; Bennouna, Jaafar; Kato, Terufumi; Gorbunova, Vera; Lee, Ki Hyeong; Shah, Riyaz; Massey, Dan; Zazulina, Victoria; Shahidi, Mehdi; Schuler, Martin; 楊志新 |
Showing items 655281-655305 of 2310128 (92406 Page(s) Totally)
<< < 26207 26208 26209 26210 26211 26212 26213 26214 26215 26216 > >>
View [10|25|50] records per page
|
